15.12BMarket Cap
35.15P/E TTM
Ascendis Pharma A/S's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Ascendis Pharma A/S is 7.24, ranking 193 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 35.15, which is 13.64% below the recent high of 39.94 and 318.62% above the recent low of -76.84.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.